1. 201 Carboplatin, paclitaxel and pembrolizumab for the first line treatment of recurrent and/or metastatic head and neck squamous cell carcinoma. (10th December 2020) Authors: Valadez, Angelica; Welsh, Madeleine; Kim, Christine; Johns, Angela; Algazi, Alain; Kang, Hyunseok; Kang, Hyunseok Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 201 Carboplatin, paclitaxel and pembrolizumab for the first line treatment of recurrent and/or metastatic head and neck squamous cell carcinoma. (9th November 2020) Authors: Valadez, Angelica; Welsh, Madeleine; Kim, Christine; Johns, Angela; Algazi, Alain; Kang, Hyunseok; Kang, Hyunseok Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A tale of two pathways: Regulation of proteostasis by UPRmt and MDPs. (February 2023) Authors: Johns, Angela; Higuchi-Sanabria, Ryo; Thorwald, Max A.; Vilchez, David Journal: Current opinion in neurobiology Issue: Volume 78(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗